Drugs to be avoided in patients with long QT syndrome: Focus on the anaesthesiological management

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 4

This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

1071

HTML

25138

Tables (1-3)

158

Sum=26367

Publishing Process of This Article

Item

Count

Browse

1203

Download

1026

Sum=2229

Apr 26, 2013 (publication date) through Apr 22, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Cardiology

ISSN

1949-8462

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Cardiol. Apr 26, 2013; 5(4): 87-93
Published online Apr 26, 2013. doi: 10.4330/wjc.v5.i4.87

Table 2 Normal QT corrected using the Bazzet’s formula duration by age and gender

QT corrected using the Bazzet’s formula
QTc value (s)	Children (1-15 yr)	Male ( > 15 yr)	Female ( > 15 yr)
Normal	< 0.44	< 0.43	< 0.45
Borderline	0.44-0.46	0.43-0.45	0.45-0.46
Prolonged	> 0.46	> 0.45	> 0.46

QTc: QT corrected using the Bazzet’s formula.

Citation: Fazio G, Vernuccio F, Grutta G, Re GL. Drugs to be avoided in patients with long QT syndrome: Focus on the anaesthesiological management. World J Cardiol 2013; 5(4): 87-93
URL: https://www.wjgnet.com/1949-8462/full/v5/i4/87.htm
DOI: https://dx.doi.org/10.4330/wjc.v5.i4.87